A green approach to the analysis of co-administered ampicillin/sulbactam and paracetamol in human urine

1. J. Noguchi and M. Gill, Sulbactam: a beta-lactamase inhibitor, Clin. Pharm. 7 (1988) 37–51.Search in Google Scholar

2. T. K. Jellison, P. S. McKinnon and M. J. Rybak, Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam, Pharmacotherapy 21 (2001) 142–148; https://doi.org/10.1592/phco.21.2.142.3411410.1592/phco.21.2.142.3411411213849Search in Google Scholar

3. D. M. Campoli-Richards and R. N. Brogden, Sulbactam/ampicillin, Drugs 33 (1987) 577–609; https://doi.org/10.2165/00003495-198733060-0000310.2165/00003495-198733060-000033038500Search in Google Scholar

4. M. C. Nahata, V. I. Vashi, R. N. Swanson, M. A. Messig and M. Chung, Pharmacokinetics of ampicillin and sulbactam in pediatric patients, Antimicrob. Agents Chemother. 43 (1999) 1225–1229; https://doi.org/10.1128/AAC.43.5.122510.1128/AAC.43.5.12258913710223940Search in Google Scholar

5. A. Walsh, H. Edwards and J. Fraser, Over-the-counter medication use for childhood fever: a cross-sectional study of Australian parents, J. Paediatr. Child Health 43 (2007) 601–606; https://doi.org/10.1111/j.1440-1754.2007.01161.x10.1111/j.1440-1754.2007.01161.x17608647Search in Google Scholar

6. S. Koling, G. Hempel, C. Lanvers, J. Boos and G. Würthwein, Monitoring paracetamol metabolism after single and repeated administration in pediatric patients with neoplastic diseases, Int. J. Clin. Pharm. Ther. 45 (2007) 496–503; https://doi.org/10.5414/cpp4549610.5414/CPP45496Search in Google Scholar

7. J. A. Forrest, J. Clements and L. Prescott, Clinical pharmacokinetics of paracetamol, Clin. Pharmacokinet. 7 (1982) 93–107.10.2165/00003088-198207020-000017039926Search in Google Scholar

8. A. Bertolini, A. Ferrari, A. Ottani, S. Guerzoni, R. Tacchi and S. Leone, Paracetamol: new vistas of an old drug, CNS Drug Rev. 12 (2006) 250–275; https://doi.org/10.1111/j.1527-3458.2006.00250.x10.1111/j.1527-3458.2006.00250.x650619417227290Search in Google Scholar

9. C. Oscier and Q. Milner, Peri-operative use of paracetamol, Anaesthesia 64 (2009) 65–72; https://doi.org/10.1111/j.1365-2044.2008.05674.x10.1111/j.1365-2044.2008.05674.x19087009Search in Google Scholar

10. C. Gonzalez, A. Garcia, R. Urrea, H. Bello and R. Zemelman, A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria, Rev. Méd. Chile 118 (1990) 548–554.Search in Google Scholar

11. S. T. Shulman, A. L. Bisno, H. W. Clegg, M. A. Gerber, E. L. Kaplan, G. Lee, J. M. Martin and C. Van Beneden, Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America, Clin. Infect. Dis. 55 (2012) e86–e102; https://doi.org/10.1093/cid/cis62910.1093/cid/cis629710803222965026Search in Google Scholar

12. S. L. Parker, S. Adnan, J. L. Ordóñez Meija, D. L. Paterson, J. Lipman, J. A. Roberts and S. C. Wallis, An UHPLC–MS/MS method for the simultaneous determination of ampicillin and sulbactam in human plasma and urine, Bioanalysis 7 (2015) 2311–2319; https://doi.org/10.4155/bio.15.14310.4155/bio.15.14326395242Search in Google Scholar

13. T. L. Tsou, Y. C. Huang, C. W. Lee, A. R. Lee, H. J. Wang and S. H. Chen, Simultaneous determination of ampicillin, cefoperazone, and sulbactam in pharmaceutical formulations by HPLC with β-cyclodextrin stationary phase, J. Sep. Sci. 30 (2007) 2407–2413; https://doi.org/10.1002/jssc.20060052910.1002/jssc.20060052917685376Search in Google Scholar

14. I. R. Miksa, M. R. Cummings and R. H. Poppenga, Multi-residue determination of anti-inflammatory analgesics in sera by liquid chromatography-mass spectrometry, J. Anal. Toxicol. 29 (2005) 95–104; https://doi.org/10.1093/jat/29.2.9510.1093/jat/29.2.9515902977Search in Google Scholar

15. X. Chen, J. Huang, Z. Kong and D. Zhong, Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of paracetamol and guaifenesin in human plasma, J. Chromatogr. B 817 (2005) 263–269; https://doi.org/10.1016/j.jchromb.2004.12.01110.1016/j.jchromb.2004.12.01115686994Search in Google Scholar

16. K. R. Ing-Lorenzini, J. A. Desmeules, M. Besson, J.-L. Veuthey, P. Dayer and Y. Daali, Two-dimensional liquid chromatography–ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: Application to a pharmacokinetic study, J. Chromatogr. A 1216 (2009) 3851–3856; https://doi.org/10.1016/j.chroma.2009.02.07110.1016/j.chroma.2009.02.07119281996Search in Google Scholar

17. A. Gałuszka, Z. Migaszewski and J. Namieśnik, The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices, Trends Anal. Chem. 50 (2013) 78–84; https://doi.org/10.1016/j.trac.2013.04.01010.1016/j.trac.2013.04.010Search in Google Scholar

18. M. Tobiszewski, A. Mechlińska and J. Namieśnik, Green analytical chemistry—theory and practice, Chem. Soc. Rev. 39 (2010) 2869–2878; https://doi.org/10.1039/B926439F10.1039/b926439f20502819Search in Google Scholar

19. L. H. Keith, L. U. Gron and J. L. Young, Green analytical methodologies, Chem. Rev. 107 (2007) 2695–2708; https://doi.org/10.1021/cr068359e10.1021/cr068359e17521200Search in Google Scholar

20. A. Gałuszka, Z. M. Migaszewski, P. Konieczka and J. Namieśnik, Analytical eco-scale for assessing the greenness of analytical procedures, Trends Anal. Chem. 37 (2012) 61–72; https://doi.org/10.1016/j.trac.2012.03.01310.1016/j.trac.2012.03.013Search in Google Scholar

21. G. Corcoran, J. Mitchell, Y. Vaishnav and E. Horning, Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine, Mol. Pharmacol. 18 (1980) 536–542.Search in Google Scholar

22. D. Nematollahi, Y. Nasseri, A. Amani and F. Fatemi, Kinetic and mechanistic study of drug-drug interaction between acetaminophen and β-lactam antibiotics, Progr. Reac. Kin. Mech. 38 (2013) 213–219; https://doi.org/10.3184%2F146867813X1364222614924010.3184/146867813X13642226149240Search in Google Scholar

23. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of analytical procedures: text and methodology, ICH, Geneva, November 2005.Search in Google Scholar